Back
Sage Therapeutics Stock Predictions
Sponsored
SAGE
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
SAGE
Sage Therapeutics
Last Price:
7.51
Seasonality Move:
14.13%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Sage Therapeutics Stock Forecast
- Over the next 52 weeks, Sage Therapeutics has on average historically risen by 6.3% based on the past 10 years of stock performance.
- Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Sage Therapeutics Stock Undervalued?
The current Sage Therapeutics [SAGE] share price is $7.50. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal. - SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sage Therapeutics has on average historically risen by 6.3% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
- Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
28.26
52-Week Low:
7.19
Prediction Charts
Market Cap:
457.88M
Price in USD:
7.50
Volume:
459.11K
Beta:
1.35
Technical Analysis
SMA50:
9.09
SMA100:
10.32
SMA200:
15.70
52-Wk Change:
-62.31%
Stock Predictions
-
Is Sage Therapeutics stock public?
Yes, Sage Therapeutics is a publicly traded company. -
What is the Sage Therapeutics stock quote today?
The Sage Therapeutics stock price is 7.50 USD today. -
How to buy Sage Therapeutics stock online?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 8.30 | 7.90 | 8.46 | 7.82 |
Sep-4 | 7.90 | 8.00 | 8.13 | 7.73 |
Sep-5 | 8.07 | 7.65 | 8.11 | 7.63 |
Sep-6 | 7.59 | 7.50 | 7.72 | 7.43 |
Sep-9 | 7.42 | 7.44 | 7.59 | 7.28 |
Sep-10 | 7.44 | 7.35 | 7.55 | 7.19 |
Sep-11 | 7.32 | 7.48 | 7.51 | 7.23 |
Sep-12 | 7.52 | 7.36 | 7.52 | 7.27 |
Sep-13 | 7.50 | 7.83 | 7.85 | 7.44 |
Sep-16 | 7.87 | 7.57 | 7.87 | 7.46 |
Sep-17 | 7.63 | 7.52 | 7.82 | 7.49 |
Sep-18 | 7.49 | 7.59 | 7.85 | 7.32 |
Sep-19 | 7.86 | 7.91 | 8.05 | 7.65 |
Sep-20 | 8.00 | 7.50 | 8.00 | 7.45 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $0.23 per share, an increase this year of $2.99 per share, and an increase next year of $1.38 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.